A new liquid biopsy approach developed by Johns Hopkins Kimmel Cancer Center investigators could revolutionize brain cancer detection by identifying circulating DNA fragments from tumors and immune ...
Artificial intelligence tools in neuro-oncology demonstrate robust performance in detecting brain metastases and predicting clinical outcomes.